WALTHAM, Mass., June 10 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. , a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, today announced its continuing success in its campaign to enforce its lateral flow patent portfolio in the German market.
Inverness currently has a number of enforcement actions pending in Germany. Since the beginning of 2004, Inverness has received judgments in its favor in Germany against three defendants. Two of these judgments remain subject to appeal. The third judgment has been resolved with compensation to Inverness and a withdrawal of the infringing products from the market.
These recent victories in Germany follow previous successful enforcements of the patents in the German courts, with four cases reaching a successful outcome in 2003 and another in 2002, and the strengthening of the patents through their successful defense in German opposition and nullity procedures before the German Patent Office. The Company has focused on the German market for its European patent enforcement initiative because of the relative speed of the German courts to reach resolution and modest cost of legal enforcement compared to U.S. patent enforcement. Since acquiring the German lateral flow patent portfolio in December 2001, Inverness has prevailed in all of the patent litigations which have been resolved.
For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com/.
Inverness Medical Innovations is a leading global developer of advanced diagnostic devices and is presently exploring new opportunities for its proprietary electrochemical and other technologies in a variety of professional diagnostic and consumer-oriented applications including immuno- diagnostics with a focus on women’s health, cardiology and infectious disease. The Company’s new product development efforts, as well as its position as a leading supplier of consumer pregnancy and fertility/ovulation tests and rapid point-of-care diagnostics, are supported by the strength of its intellectual property portfolio. Inverness is headquartered in Waltham, Massachusetts.
Contact: Doug Guarino Director of Corporate Relations 781-647-3900
Inverness Medical Innovations, Inc.
CONTACT: Doug Guarino, Director of Corporate Relations of InvernessMedical Innovations, +1-781-647-3900
Web site: http://www.invernessmedical.com/